Skip Navigation

This Article
Right arrow Full Text (PDF )
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kilpatrick, D.C.
Right arrow Articles by Liston, W.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kilpatrick, D.C.
Right arrow Articles by Liston, W.A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 8, No. 10, pp. 1645-1649, 1993
© 1993 European Society of Human Reproduction and Embryology

research-article

Immunology: Influence of histocompatibility antigens in recurrent spontaneous abortion and its relevance to leukocyte immunotherapy

D.C. Kilpatrick1 and W.A. Liston2

Department of Transfusion Medicine 2 Forrest Road, Edinburgh EH1 2QN 2Gynaecology Pavilion, The Royal Infirmary Edinburgh, UK

Correspondence: 1To whom correspondence should be addressed

A total of 108 couples with recurrent spontaneous abortion (RSA) were studied to investigate the possible influence of histocompatibility antigens (HLA) on their condition and its management. HLA-B18 was shown to be at a higher frequency in RSA women, but not significantly so after statistical correction. Just over half the RSA women shared two or more HLA-A, B or DR antigens with their partners (P < 0.01), but this group did not differ from the others in clinical or laboratory features, nor in subsequent pregnancy success rate. Leukocyte immunotherapy in which the donor shared at least one HLA-DR antigen with his partner was not associated with a significant improvement in subsequent pregnancy outcome compared with HLA-DR mismatched immunotherapy. HLA antibody production following leukocyte immunotherapy was influenced by both inoculum size and degree of HLA incompatibility, but had no effect on birthweight. Tissue-typing investigations are not indicated for individual RSA patients seeking advice or treatment.

Key words: HLA antibodies/HLA antigen sharing/leukocyte immunotherapy/recurrent spontaneous abortion


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.